Skip to content
Open access

Atherogenic Index of Plasma as a Cardiovascular Risk Marker in Subclinical Hypothyroidism. A Comparative Study with Conventional Lipid Indices

Aug 2026 · Annals of Pathology and Laboratory Medicine · 0 citations

TL;DR

AIP correlated significantly with serum TSH levels and showed a superior diagnostic performance and may serve as a sensitive marker of cardiovascular risk in SCH patients as compared to traditional lipid markers, suggesting that it may serve as a sensitive marker of cardiovascular risk in SCH patients as compared to traditional lipid markers.

Abstract

Background: Dyslipidemia, characterized by an imbalance in lipid profiles, is a recognized factor in the development of atherosclerosis and cardiovascular diseases. Current evidence suggests that non-traditional serum lipid ratios are more effective than traditional serum lipid parameters in predicting vascular diseases. Therefore, this study aims to investigate the relationship between atherogenic index of plasma (AIP; logarithm TG/HDL-c), Castelli risk index I and II (TG/HDL-c and LDL-c/HDL-c, respectively), and atherogenic coefficient (AC; non-HDL-c/HDL-c) using traditional serum lipid parameters (triglyceride (TG), total cholesterol (TC), LDL cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c)) with TSH in subclinical hypothyroidism. Material and Methods: The study was designed as a hospital-based cross-sectional observational study conducted for a period of four months from January–April 2026, in Central Clinical Laboratory and Department of Medicine of Adesh Institute of Medical Sciences and Research, Bathinda, a tertiary care teaching hospital in Punjab. A total of 200 subjects (100 cases and 100 controls) were enrolled in the study.Results: Lipid parameters including total cholesterol (p=0.001), triglycerides (p=0.001), HDL (p=0.049), LDL (p=0.001), and VLDL (p=0.001) were significantly higher in cases. Atherogenic indices such as AIP, Castelli Risk Index I, Castelli Risk Index II and AC were also significantly elevated (p<0.001), indicating increased cardiovascular risk among SCH patients. ROC curve analysis demonstrated that AIP showed the highest area under the curve (AUC=0.751), followed closely by CRI-I (AUC=0.748), CRI-II (AUC=0.744) and AC (AUC=0.656) while LDL cholesterol showed comparatively lower discriminatory ability (AUC=0.615). There was a significant difference (p=0.011) in area under curve for AIP and LDL when compared together.Conclusion: AIP correlated significantly (p=0.005) with serum TSH levels and showed a superior diagnostic performance (z=-2.542, p=0.011) (AUC for AIP=0.751) compared to LDL (AUC for LDL=0.651), suggesting that it may serve as a sensitive marker of cardiovascular risk in SCH patients as compared to traditional lipid markers.

Read PDF

Similar papers

Open access Sep 2026

Lipid parameters and the risk of incident CKD: an analysis of conventional and composite lipid indices

Dyslipidemia is predominant in chronic kidney disease (CKD) patients and is usually characterized by high levels of triglyceride (TG), decreased high-density lipoprotein cholesterol (HDL-C), and normal or slightly elevated low-density lipoprotein cholesterol (LDL-C). Nevertheless, the link between this distinct d...

Dan-Dan Li, Zi-Han Song, Xiao-Ci Wang et al. · 0 citations
Sep 2026

Clinical Utility of the Atherogenic Plasma Index for Identifying Atherogenic Dyslipidemia: A Large Cross-Sectional Analysis Stratified by Sex and Thyroid Status.

BACKGROUND The atherogenic plasma index (AIP) has emerged as a promising marker reflecting the balance between triglyceride (TG)-rich lipoproteins and high-density lipoprotein cholesterol (HDL-C). However, its clinical utility in identifying atherogenic dyslipidemia (AD), particularly across sex and thyroid function su...

Fatih Çon, Alev Kural, Duygu Sari Ak · 0 citations
Open access Sep 2026

Associations of apolipoprotein A1, apolipoprotein B, and their ratio with novel cardiometabolic indices in adults with coronary artery disease

Background Circulating apolipoprotein A1 (ApoA1) and apolipoprotein B (ApoB) have been proposed as vital biomarkers in the pathological process of coronary heart disease (CAD). However, their associations with novel cardiometabolic indices [triglyceride glucose body mass index (TyG-BMI), atherogenic index of plasma (AI...

Ping Hu, Nan Lu, Jie Wang et al. · 0 citations
Review Open access Sep 2026

Apolipoprotein B in cardiovascular risk assessment: beyond traditional lipid markers

Apolipoprotein B (ApoB) serves as the structural backbone of triglyceride (TG)-rich lipoproteins and low-density lipoprotein (LDL) particles and plays a key role in lipid transport. A growing body of evidence indicates that circulating ApoB levels are closely associated with the development of cardiovascular diseases s...

Ling-Ling Li, Yi-Xuan Feng, Xiao-Ya Li et al. · 0 citations
Open access Aug 2026

HsCRP and Atherogenic Index as Markers of Cardiovascular Risk in Type 2 Diabetes Mellitus: A Cross-Sectional Analysis

Elevated hsCRP is strongly associated with atherogenic lipid abnormalities and increased cardiovascular risk in patients with type 2 diabetes mellitus and the combined assessment of inflammatory markers and Atherogenic Index of Plasma may enhance early cardiovascular risk stratification beyond traditional lipid profile...

Shantanu Dutta, Mahmudul Haque, Shantunu Chowdhury et al. · 0 citations
Open access Sep 2026

Correlation Between Vitamin D3, Atherogenic Indices of Plasma and Cardiometabolic Biomarkers in Diabetic Patients

Background: Cardiometabolic disease is a cluster of interconnected cardiovascular and metabolic disorders. These include obesity, insulin resistance, hypertension, heart disease and type 2 diabetes. In this study, focus was to identify correlation between serum vitamin D3 levels along with Atherogenic Indices of Plasma...

Urooj Ata, N. Raja, S. Malik et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.